Renal outcomes following fundus fluorescein angiography in patients with diabetic nephropathy: Incidence, risk factors and three‐month kidney function changes
- 27 August 2026
- journal article
- research article
- Published by Wiley in Diabetic Medicine
- Vol. 43 (10) , e70455
Abstract
Aims: The aim of this study was to determine the incidence of contrast‐associated acute kidney injury (CA‐AKI) after fundus fluorescein angiography (FFA) in a high‐risk diabetic nephropathy (DN) population, to identify clinical predictors of renal injury and to evaluate the effect of acute exacerbation on 3‐month eGFR changes. Methods: This retrospective cohort study included 307 patients diagnosed with DN. CA‐AKI was defined as an increase of ≥0.3 mg/dL in serum creatinine level within 48 h or ≥1.5‐fold increase within 7 days after FFA exposure. Patients' medication history and 3‐month post‐procedure eGFR values were recorded. Independent factors predicting CA‐AKI development were assessed using multivariate logistic regression, while long‐term losses were evaluated using linear regression and ROC analysis. Results: CA‐AKI occurred in 5.2% of patients. Lower baseline eGFR and diuretic use were independent predictors of CA‐AKI. ROC analysis identified a baseline eGFR threshold of ≤32 mL/min/1.73 m 2 for increased CA‐AKI risk, and a combined model including eGFR and diuretic use demonstrated superior predictive accuracy. Although SGLT‐2 inhibitor use was associated with CA‐AKI in univariate analysis, it was not independently significant after adjustment. Notably, 13 of 16 patients (81.3%) who developed CA‐AKI experienced persistent eGFR decline at 3 months, and CA‐AKI was the strongest predictor of subsequent renal function deterioration. Conclusions: FFA is associated with a clinically meaningful risk of CA‐AKI in patients with advanced DN, particularly in those with eGFR ≤32 mL/min/1.73 m 2 and concurrent diuretic therapy. Careful pre‐procedural risk stratification, individualized hydration and post‐procedure renal monitoring are warranted.Keywords
This publication has 27 references indexed in Scilit:
- Type 2 Diabetes Mellitus: A Comprehensive Review of Pathophysiology, Comorbidities, and Emerging TherapiesComprehensive Physiology, 2025
- Sodium-glucose cotransporter 2 inhibitors and contrast-induced nephropathy risk: a meta-analysisEuropean Journal of Clinical Pharmacology, 2024
- Optical coherence tomography angiography for the differentiation of diabetic nephropathy from non-diabetic renal diseasePhotodiagnosis and Photodynamic Therapy, 2024
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney DiseaseKidney International, 2024
- Contrast-Associated Acute Kidney InjuryInterventional Cardiology Clinics, 2023
- Parapapillary Choroidal Microvasculature Predicts Diabetic Retinopathy Progression and Diabetic Macular Edema Development: A Three-Year Prospective StudyAmerican Journal of Ophthalmology, 2022
- Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus ConferenceKidney International, 2021
- Intra-operative fluorescein videoangiography-related nephrotoxicity in intracranial aneurysm surgery: Single center, observational cohort studyClinical Neurology and Neurosurgery, 2021
- Relationship between diabetic retinopathy and diabetic nephropathy; A longitudinal follow-up study from a tertiary care unit of Karachi, PakistanDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020
- Conflicting and New Risk Factors for Contrast Induced NephropathyJournal of Urology, 2007